Visual Patterns

• • Reports emphasize dynamic rather than static visual distortion: surfaces and objects appeared to breathe, ripple, contract, and expand.
• • Neon coloration was observed, consistent with the participant’s prior expectation or knowledge of reported 4-HO-compound effects; expectation effects cannot be separated from pharmacological effects in this design.
• • Code-like imagery was reportedly observable but degraded by competing global distortions, limiting fine-grained inspection and documentation.
• • The account suggests lower apparent code clarity and usability than the participant’s informal DMT comparison, but no standardized rating or blinded comparison was obtained.

Behavioral Patterns

• • The participant actively searched for code and attempted to draw it, but discontinued because ongoing visual distortions impaired observation and reproduction.
• • A clear or relatively clear headspace co-occurred with complex visual effects, indicating that subjective cognitive intensity and visual-code clarity may not covary directly.
• • The internally heard dialogue influenced subsequent interpretation and motivated a search for additional compound classes; this illustrates how set, expectation, and post hoc meaning-making may shape the research narrative.
• • No systematic measurement was reported for onset, peak, duration, persistence after laser removal, effects of looking away, or whether the code could be intentionally modulated.

Technical Patterns

• • The experiment used diffraction-based laser projection at approximately 5 m, with a stated 650 nm, 1 mW laser and an additional 488 nm laser.
• • The report does not specify which wavelength produced the described code, whether both were tested separately, or whether laser power and beam geometry were matched across wavelengths.
• • The diffraction grating, projection surface, beam alignment, ambient lighting, viewing angle, camera settings, and surface reflectance were not documented in sufficient detail to reproduce the observation.
• • The use of passion-flower extract introduces an uncertain pharmacological co-variable. Its active constituents, dose equivalence, bioavailability, and interaction with 4-HO-EPT were not measured.

Scientific Significance

The report contributes a preliminary single-session observation that code-like visual phenomena may occur outside DMT, at least phenomenologically, under 4-HO-EPT. Its most useful implication is not that 4-HO-EPT produces a specific objective code, but that visual-code reports may depend on the interaction among drug state, visual instability, attention, expectation, laser parameters, and diffraction artifacts. The reduced clarity relative to the participant’s DMT baseline is compatible with several explanations—including compound-specific effects, dose, co-administration, attentional competition, or technical differences—and cannot be attributed to any one factor from this experiment. The reported internal voice and browser-history event should be documented as subjective experiences requiring independent verification rather than interpreted as evidence of a nonphysical entity or external communication.

Methodological Notes

Strengths include recording dose, approximate laser wavelength, power, projection distance, and the participant’s phenomenological observations, as well as attempting direct visual documentation. Major limitations are the single-participant, uncontrolled design; absence of a sober or drug-only laser control; uncertain 488 nm testing details; no objective code-identification criterion; no standardized ratings of clarity, persistence, or complexity; reliance on retrospective narrative; and comparison with DMT under apparently non-equivalent conditions. Passion-flower extract is a substantial confound because its composition and monoamine-oxidase-related effects are uncertain, and the term mild MAOI should not be treated as a quantified pharmacological dose. The browser-history observation requires technical logs, synchronized timestamps, multiple browsers or devices, and independent checks before being considered evidence of data loss. Any use of MAOI-like substances with serotonergic psychedelics also raises safety concerns and should not be experimentally combined without qualified medical oversight.

Recommendations

Future sessions should isolate variables using a preregistered protocol: test one wavelength at a time, document exact laser specifications and beam geometry, standardize projection surface and lighting, and include non-drug and drug-only controls. Avoid adding poorly characterized extracts or MAOI-like substances; if drug research is pursued, use appropriate clinical and toxicological oversight. Record baseline, onset, peak, and offset ratings for code presence, clarity, stability, color, motion, and ability to interact, using predefined scales. Capture synchronized video of the projected pattern, the participant’s verbal reports, and room conditions, while avoiding direct laser exposure to the eyes and complying with applicable laser-safety standards. Independent raters should assess whether recorded images differ from diffraction patterns or ordinary visual artifacts, ideally with blinded presentation. Replication across participants and doses is required before making claims about compound-specific code quality or comparisons such as '4K' versus '8K.' For unusual perceptual or voice-hearing experiences, include post-session wellbeing monitoring and encourage professional support if they persist, recur while sober, or become distressing.